Division of Nephrology and Hypertension, Vanderbilt University Medical Center, 1161 21st Avenue South, MCN South-3305, Nashville, TN, 37232, USA.
Icahn School of Medicine at Mount Sinai, Division of Nephrology, New York City, NY, USA.
BMC Nephrol. 2022 Jun 21;23(1):217. doi: 10.1186/s12882-022-02854-z.
Most patients on peritoneal dialysis (PD) in the United States choose automated PD via cyclers. Cyclers have evolved considerably over time with older versions (e.g. HomeChoice Pro) replaced by more sophisticated and technologically advanced versions (e.g. Amia). Understanding the effect that different cyclers and their features have on patient treatments and support needs is important. METHODS: Single center study with retrospective and prospective arms. Retrospective arm: Patients > 18 years old, on Amia or HomeChoice Pro (HC) for ≥ 3 months between 8/1/17 and 1/31/18. Number of office/telephone encounters, PD-related emergency room visits/hospitalizations, PD training days, and dialysis adequacy (Kt/V) were recorded. Prospective arm: Patients > 18 years old, on Amia or HC for ≥ 3 months between 9/1/19 and 2/29/20 were surveyed on their comfort, troubleshooting, satisfaction and reported assistance needed with their cyclers.
Retrospective arm: 43 patients on AMIA and 27 patients on HC. Number of PD training days, Kt/Vs achieved, PD-related telephone/office encounters, and PD-related emergency room visits/hospitalizations were all similar. Prospective Arm: 32 patients on AMIA and 6 patients on HC. Higher rate of patient comfort with AMIA, but similar overall patient satisfaction with both cyclers. No difference in terms of patient-reported troubleshooting issues requiring assistance.
Despite the difference in features provided between the 2 cyclers, patient overall satisfaction rates were high irrespective of the PD cycler. The HomeChoice Pro and AMIA cycler patients had a similar number of PD training days, PD-related telephone/office encounters, and PD-related emergency room visits/hospitalizations.
This study was approved by the Icahn School of Medicine at Mount Sinai Institutional Review Board (IRB-17-02704).
美国大多数接受腹膜透析（PD）的患者选择通过自动腹膜透析机进行 PD。随着时间的推移，腹膜透析机已经有了很大的发展，旧版本（例如 HomeChoice Pro）已经被更复杂和技术先进的版本（例如 Amia）所取代。了解不同腹膜透析机及其功能对患者治疗和支持需求的影响非常重要。
这项单中心研究包括回顾性和前瞻性两个部分。回顾性部分：患者年龄大于 18 岁，在 2017 年 8 月 1 日至 2018 年 1 月 31 日期间，使用 Amia 或 HomeChoice Pro（HC）至少 3 个月。记录门诊/电话就诊次数、PD 相关急诊就诊/住院次数、PD 培训天数和透析充分性（Kt/V）。前瞻性部分：患者年龄大于 18 岁，在 2019 年 9 月 1 日至 2020 年 2 月 29 日期间，使用 Amia 或 HC 至少 3 个月，对他们的舒适度、故障排除、满意度以及报告的对腹膜透析机的帮助需求进行调查。
回顾性部分：共有 43 名患者使用 AMIA，27 名患者使用 HC。PD 培训天数、Kt/V 值、PD 相关的门诊/电话就诊次数和 PD 相关的急诊就诊/住院次数均相似。前瞻性部分：32 名患者使用 AMIA，6 名患者使用 HC。患者对 AMIA 的舒适度满意度更高，但对两种腹膜透析机的总体满意度相似。在需要帮助解决故障的患者报告问题方面，两种腹膜透析机没有差异。
尽管两种腹膜透析机的功能存在差异，但无论使用哪种腹膜透析机，患者的总体满意度都很高。HomeChoice Pro 和 AMIA 腹膜透析机的患者 PD 培训天数、PD 相关的门诊/电话就诊次数和 PD 相关的急诊就诊/住院次数相似。
这项研究得到了西奈山伊坎医学院机构审查委员会（IRB-17-02704）的批准。
